Breast Cancer Research and Treatment

Progression of Premalignant MCF10AT Generates Heterogeneous Malignant Variants with Characteristic Histologic Types and Immunohistochemical Markers
pp. 235-240(6)
Authors: Strickland L.B.; Dawson P.J.; Santner S.J.; Miller F.R.

Loss of Heterozygosity in Bilateral Breast Cancer
pp. 241-251(11)
Authors: Kollias J.; Man S.; Marafie M.; Carpenter K.; Pinder S.; Ellis I.O.; Blamey R.W.; Cross G.; Brook J.D.

Utilization of Professional Supportive Care Services by Women with Breast Cancer
pp. 253-258(6)
Authors: Gray R.E.; Goel V.; Fitch M.I.; Franssen E.; Chart P.; Greenberg M.; Bakker D.; Labrecque M.; Hollowaty E.; Godel R.; Hampson A.W.

Antimitotic and Cytotoxic Effects of Theophylline in MDA-MB-231 Human Breast Cancer Cells
pp. 259-267(9)
Authors: Slotkin T.A.; Seidler F.J.

Inflammatory Breast Carcinoma: Pathological or Clinical Entity?
pp. 269-273(5)
Authors: Amparo R.S.; Angel C.D.M.; Ana L.H.; Antonio L.C.; Vicente M.S.; Carlos F-M.; Vicente G.P.

Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic Factors
pp. 275-286(12)
Authors: Kuehn T.; Klauss W.; Darsow M.; Regele S.; Flock F.; Maiterth C.; Dahlbender R.; Wendt I.; Kreienberg R.

Effect of Melatonin and Linolenic Acid on Mammary Cancer in Transgenic Mice with c-neu Breast Cancer Oncogene
pp. 287-296(10)
Authors: Rao G.N.; Ney E.; Herbert R.A.